Asembia’s AXS26 Summit
Syneos Health is heading to the Asembia AXS26 Summit with a clear message for biopharma leaders: in today’s access environment, value alone isn’t enough—execution determines impact. As pricing pressure intensifies, payers consolidate and direct-to-patient models expand, manufacturers can no longer rely on fragmented access strategies. Coverage does not guarantee access, and access does not guarantee volume. At AXS26, our experts will share how we help customers define, demonstrate and operationalize value across the commercial ecosystem—from early strategy through launch and lifecycle optimization—so patients start therapy faster and brands perform with confidence.
Through smart sourcing and plug-and-play deployment models, Syneos Health integrates market access strategy, field reimbursement, patient education and engagement, training, technology and analytics into one orchestrated approach. The result is coordinated execution, reduced friction and measurable outcomes at scale, without sacrificing control. Whether you are navigating a complex launch or optimizing an in-market brand, we help you move from value to commercial volume, without the gaps.
Meet with Us
Meet with us onsite to explore how we can help you drive faster, lower-risk launches and more agile lifecycle management. And don’t miss the Syneos Health Podcast recording from the booth #1529 on the exhibit floor, featuring candid, commute-sized conversations with industry leaders on the forces reshaping access, commercialization and patient support. Stop by to join the dialogue—and be part of the conversation that’s accelerating impact from lab to life.
Featured Sessions
PANEL | The Future of Cancer Care: Navigating Headwinds & Opportunities to Advance Access, Affordability & Outcomes
April 29 | 10am

Chris Van Denburg
Managing Director Value and Access
Syneos Health

Micaila Ruiz
VP Specialty Franchises
Optum

Tina Valbh
Managing Partner
PharmaKonnect; CIO Tina's Warriors

Austin Fisher
Vice President, Patient & Channel Access
Autolus Therapeutics
Featured Session
PANEL | Efficiency is the New Innovation: Why Pharma Can’t Afford to Go It Alone
April 29 | 1pm

Kim Plesnarski
VP Strategic Marketing Market Access & Patient Support,
Syneos Health

Angela Wlodar
SVP Strategic Solutions
Syneos Health

Terry Milton
AVP Field Reimbursement Services
Eli Lilly

Brian Siemak
Vice President of Portfolio Strategy
Mannkind
Related Content:
Want to learn more? Explore Insights Hub for our latest perspectives, subscribe to our podcast, or click the resources below:
WEBINAR | Beyond Forecasts: Navigating MFN Uncertainty
BLOG | Strategic Partnerships in Patient Support: Leaner Operations, Better Outcomes